Alembic Pharmaceuticals Limited (APLLTD) — Capital Reinvestment Ratio
Alembic Pharmaceuticals Limited (APLLTD) has a Capital Reinvestment Ratio of 0.71x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs4.03 Billion) in capital expenditures (Rs2.88 Billion). Check APLLTD tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Alembic Pharmaceuticals Limited Capital Reinvestment Ratio (2011–2025)
This chart tracks Alembic Pharmaceuticals Limited's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see Alembic Pharmaceuticals Limited operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Alembic Pharmaceuticals Limited (2011–2025)
Year-by-year Capital Reinvestment Ratio for Alembic Pharmaceuticals Limited from 2011 to 2025. See Alembic Pharmaceuticals Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 6.41x | Rs879.70 Million | Rs5.64 Billion | ▲ +1471.5% |
| 2024 | 0.41x | Rs8.03 Billion | Rs3.27 Billion | ▼ -33.4% |
| 2023 | 0.61x | Rs7.24 Billion | Rs4.43 Billion | ▼ -20.5% |
| 2022 | 0.77x | Rs5.52 Billion | Rs4.26 Billion | ▲ +71.0% |
| 2021 | 0.45x | Rs14.63 Billion | Rs6.60 Billion | ▼ -72.5% |
| 2020 | 1.64x | Rs4.49 Billion | Rs7.35 Billion | ▲ +73.8% |
| 2019 | 0.94x | Rs8.12 Billion | Rs7.64 Billion | ▼ -64.2% |
| 2018 | 2.63x | Rs3.12 Billion | Rs8.22 Billion | ▲ +61.5% |
| 2017 | 1.63x | Rs2.89 Billion | Rs4.70 Billion | ▲ +399.1% |
| 2016 | 0.33x | Rs9.30 Billion | Rs3.04 Billion | ▼ -74.9% |
| 2015 | 1.30x | Rs1.72 Billion | Rs2.24 Billion | ▲ +275.2% |
| 2014 | 0.35x | Rs2.36 Billion | Rs819.63 Million | ▲ +6.9% |
| 2013 | 0.32x | Rs2.65 Billion | Rs859.73 Million | ▼ -25.4% |
| 2012 | 0.44x | Rs1.41 Billion | Rs612.56 Million | ▼ -33.1% |
| 2011 | 0.65x | Rs961.81 Million | Rs625.38 Million | — |